Cargando…

Accelerated tumor growth in mice deficient in DNAM-1 receptor

Since the identification of ligands for human and mouse DNAM-1, emerging evidence has suggested that DNAM-1 plays an important role in the T cell– and natural killer (NK) cell–mediated recognition and lysis of tumor cells. However, it remains undetermined whether DNAM-1 is involved in tumor immune s...

Descripción completa

Detalles Bibliográficos
Autores principales: Iguchi-Manaka, Akiko, Kai, Hirayasu, Yamashita, Yumi, Shibata, Kai, Tahara-Hanaoka, Satoko, Honda, Shin-ichiro, Yasui, Teruhito, Kikutani, Hitoshi, Shibuya, Kazuko, Shibuya, Akira
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605241/
https://www.ncbi.nlm.nih.gov/pubmed/19029379
http://dx.doi.org/10.1084/jem.20081611
_version_ 1782162830432141312
author Iguchi-Manaka, Akiko
Kai, Hirayasu
Yamashita, Yumi
Shibata, Kai
Tahara-Hanaoka, Satoko
Honda, Shin-ichiro
Yasui, Teruhito
Kikutani, Hitoshi
Shibuya, Kazuko
Shibuya, Akira
author_facet Iguchi-Manaka, Akiko
Kai, Hirayasu
Yamashita, Yumi
Shibata, Kai
Tahara-Hanaoka, Satoko
Honda, Shin-ichiro
Yasui, Teruhito
Kikutani, Hitoshi
Shibuya, Kazuko
Shibuya, Akira
author_sort Iguchi-Manaka, Akiko
collection PubMed
description Since the identification of ligands for human and mouse DNAM-1, emerging evidence has suggested that DNAM-1 plays an important role in the T cell– and natural killer (NK) cell–mediated recognition and lysis of tumor cells. However, it remains undetermined whether DNAM-1 is involved in tumor immune surveillance in vivo. We addressed this question by using DNAM-1–deficient mice. DNAM-1–deficient cytotoxic T lymphocyte (CTL) and NK cells showed significantly less cytotoxic activity against DNAM-1 ligand-expressing tumors in vitro than wild-type (WT) cells. The methylcholanthrene (MCA)-induced fibrosarcoma cell line Meth A expressed the DNAM-1 ligand CD155, and DNAM-1–deficient mice showed increased tumor development and mortality after transplantation of Meth A cells. Moreover, the DNAM-1–deficient mice developed significantly more DNAM-1 ligand-expressing fibrosarcoma and papilloma cells in response to the chemical carcinogens MCA and 7,12-dimethylbenz[a]anthracene (DMBA), respectively, than did WT mice. These results indicate that DNAM-1 plays an important role in immune surveillance of tumor development.
format Text
id pubmed-2605241
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-26052412009-06-22 Accelerated tumor growth in mice deficient in DNAM-1 receptor Iguchi-Manaka, Akiko Kai, Hirayasu Yamashita, Yumi Shibata, Kai Tahara-Hanaoka, Satoko Honda, Shin-ichiro Yasui, Teruhito Kikutani, Hitoshi Shibuya, Kazuko Shibuya, Akira J Exp Med Brief Definitive Reports Since the identification of ligands for human and mouse DNAM-1, emerging evidence has suggested that DNAM-1 plays an important role in the T cell– and natural killer (NK) cell–mediated recognition and lysis of tumor cells. However, it remains undetermined whether DNAM-1 is involved in tumor immune surveillance in vivo. We addressed this question by using DNAM-1–deficient mice. DNAM-1–deficient cytotoxic T lymphocyte (CTL) and NK cells showed significantly less cytotoxic activity against DNAM-1 ligand-expressing tumors in vitro than wild-type (WT) cells. The methylcholanthrene (MCA)-induced fibrosarcoma cell line Meth A expressed the DNAM-1 ligand CD155, and DNAM-1–deficient mice showed increased tumor development and mortality after transplantation of Meth A cells. Moreover, the DNAM-1–deficient mice developed significantly more DNAM-1 ligand-expressing fibrosarcoma and papilloma cells in response to the chemical carcinogens MCA and 7,12-dimethylbenz[a]anthracene (DMBA), respectively, than did WT mice. These results indicate that DNAM-1 plays an important role in immune surveillance of tumor development. The Rockefeller University Press 2008-12-22 /pmc/articles/PMC2605241/ /pubmed/19029379 http://dx.doi.org/10.1084/jem.20081611 Text en © 2008 Iguchi-Manaka et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Brief Definitive Reports
Iguchi-Manaka, Akiko
Kai, Hirayasu
Yamashita, Yumi
Shibata, Kai
Tahara-Hanaoka, Satoko
Honda, Shin-ichiro
Yasui, Teruhito
Kikutani, Hitoshi
Shibuya, Kazuko
Shibuya, Akira
Accelerated tumor growth in mice deficient in DNAM-1 receptor
title Accelerated tumor growth in mice deficient in DNAM-1 receptor
title_full Accelerated tumor growth in mice deficient in DNAM-1 receptor
title_fullStr Accelerated tumor growth in mice deficient in DNAM-1 receptor
title_full_unstemmed Accelerated tumor growth in mice deficient in DNAM-1 receptor
title_short Accelerated tumor growth in mice deficient in DNAM-1 receptor
title_sort accelerated tumor growth in mice deficient in dnam-1 receptor
topic Brief Definitive Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605241/
https://www.ncbi.nlm.nih.gov/pubmed/19029379
http://dx.doi.org/10.1084/jem.20081611
work_keys_str_mv AT iguchimanakaakiko acceleratedtumorgrowthinmicedeficientindnam1receptor
AT kaihirayasu acceleratedtumorgrowthinmicedeficientindnam1receptor
AT yamashitayumi acceleratedtumorgrowthinmicedeficientindnam1receptor
AT shibatakai acceleratedtumorgrowthinmicedeficientindnam1receptor
AT taharahanaokasatoko acceleratedtumorgrowthinmicedeficientindnam1receptor
AT hondashinichiro acceleratedtumorgrowthinmicedeficientindnam1receptor
AT yasuiteruhito acceleratedtumorgrowthinmicedeficientindnam1receptor
AT kikutanihitoshi acceleratedtumorgrowthinmicedeficientindnam1receptor
AT shibuyakazuko acceleratedtumorgrowthinmicedeficientindnam1receptor
AT shibuyaakira acceleratedtumorgrowthinmicedeficientindnam1receptor